Several studies have shown that FGFs, particularly FGF-2, FGF-19, and FGF-23, are altered in diabetes and may be associated with complications such as nephropathy and impaired wound healing [8,11,12,13]. This evidence concerns the gene FGF2 and diabetes mellitus.